Fletcher Payne - 19 Jan 2023 Form 4 Insider Report for Aptose Biosciences Inc. (APTOF)

Role: SR VP & Chief Fin. Officer
Signature: /s/ Fletcher Payne
Issuer symbol: APTOF
Transactions as of: 19 Jan 2023
Net transactions value: $0
Form type: 4
Filing time: 23 Jan 2023, 18:57:29 UTC
Previous filing: 21 Sep 2022
Next filing: 07 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APTO	Common Shares	Award	$0	+100,000		$0.000000	100,000	19 Jan 2023	Direct
holding	APTO	Common Shares						10,000	19 Jan 2023	Held by Fletcher Payne 2019 Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APTO	Employee Stock Option (Right to Buy)	Award	$0	+200,000		$0.000000	200,000	19 Jan 2023	Common Shares	200,000	$0.6600	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Fifty percent (50%) of the options vest on January 19, 2024; the remaining fifty percent (50%) vest as follows: One-third (1/3) on January 19, 2025; one-third (1/3) on January 19, 2026; and one-third (1/3) on January 19, 2027.